Old Web
English
Sign In
Acemap
>
authorDetail
>
Maryann J. Kwa
Maryann J. Kwa
New York University
Breast cancer
Medicine
Pathology
Oncology
Chemotherapy
4
Papers
86
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Risk for SARS-CoV-2 infection in patients with breast cancer treated with chemotherapy, biologic therapy or active surveillance: Patient outcomes from multicenter institution in New York
2021
Journal of Clinical Oncology
Nibash Budhathoki
John Kucharczyk
Nina DAbreo
Maryann J. Kwa
Magdalena Plasilova
Shubhada Dhage
Alexander A. Hindenburg
Joanna Lee
Megan Winner
Alison Daly
Phyu Phyu Soe
Angela Ramdhanny
Freya Schnabel
Ruth Oratz
James L. Speyer
Yelena Novik
M. Meyers
Simon W. Jones
Sylvia Adams
Douglas K. Marks
Show All
Source
Cite
Save
Citations (0)
Phase II trial of nivolumab with chemotherapy as neoadjuvant treatment in inflammatory breast cancer.
2019
Journal of Clinical Oncology
Maryann J. Kwa
Nancy Tray
Francisco J. Esteva
Yelena Novik
James L. Speyer
Ruth Oratz
M. Meyers
Franco M. Muggia
Victor Ty
Andrea B. Troxel
Robert J. Schneider
Sylvia Adams
Show All
Source
Cite
Save
Citations (1)
Checkpoint inhibitors in triple‐negative breast cancer (TNBC): Where to go from here
2018
Cancer
Maryann J. Kwa
Sylvia Adams
Show All
Source
Cite
Save
Citations (82)
Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer.
2017
Journal of Clinical Oncology
Maryann J. Kwa
Alyssa Iwano
Francisco J. Esteva
Yelena Novik
James L. Speyer
Ruth Oratz
Marleen Meyers
Deborah Axelrod
Rebecca Hogan
Sandra Mendoza
Judith D. Goldberg
Franco M. Muggia
Sylvia Adams
Show All
Source
Cite
Save
Citations (3)
1